toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Luedi, M. M., Singh, S. K., Mosley, J. C., Hatami, M., Gumin, J., Sulman, E. P., et al. (2017). A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. J Neurosurg Anesthesiol, 29(1), 46–58.
toggle visibility
Bijangi-Vishehsaraei, K., Reza Saadatzadeh, M., Wang, H., Nguyen, A., Kamocka, M. M., Cai, W., et al. (2017). Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. J Neurosurg, , 1–12.
toggle visibility
Rosager, A. M., Sorensen, M. D., Dahlrot, R. H., Boldt, H. B., Hansen, S., Lathia, J. D., et al. (2017). Expression and prognostic value of JAM-A in gliomas. J Neurooncol, .
toggle visibility
Emery, I. F., Gopalan, A., Wood, S., Chow, K. - H., Battelli, C., George, J., et al. (2017). Expression and function of ABCG2 and XIAP in glioblastomas. J Neurooncol, 133(1), 47–57.
toggle visibility
Azoulay, M., Santos, F., Shenouda, G., Petrecca, K., Oweida, A., Guiot, M. C., et al. (2017). Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. J Neurooncol, 132(3), 419–426.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print